Quotient Limited opens an office

To reinforce growth opportunities in emerging markets

START READING

Tuesday 26 July 2022

Quotient Limited, a commercial-stage diagnostics company, has announced the opening of a new office in Dubai, and the incorporation of its subsidiary Quotient Middle East and Africa FZ LLC. The move comes as part of the company’s expansion plans to better support customers in the region.

With a strong base of distributors in the Middle East and North Africa, the opening of Quotient’s Dubai office is expected to reinforce growth opportunities in emerging markets and is the latest step in establishing the company’s global presence.

It is also part of Quotient’s goal to improve clinical practices and increase laboratory efficiencies across the globe.

Founded in 2007 and headquartered in Switzerland, Quotient Limited focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is also engaged in developing MosaiQ, its automated microarray technology platform.

In early 2022, the company received the CE Mark for its MosaiQ Extended Immunohematology Microarray, which increases the range of tests that can be run on its MosaiQ consolidated testing platform. The company is now commercializing the microarray for use in the European Union and other CE Mark-recognizing geographies.